Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Reactive and undifferentiated arthritis in North Africa: use of PCR for detection of Chlamydia trachomatis.

Kuipers JG, Sibilia J, Bas S, Gaston H, Granfors K, Vischer TL, Hajjaj-Hassouni N, Ladjouze-Rezig A, Sellami S, Wollenhaupt J, Zeidler H, Schumacher HR, Dougados M.

Clin Rheumatol. 2009 Jan;28(1):11-6. doi: 10.1007/s10067-008-0968-z. Epub 2008 Aug 8.

PMID:
18688674
2.

Fibromyalgia: a randomised, controlled trial of a treatment programme based on self management.

Cedraschi C, Desmeules J, Rapiti E, Baumgartner E, Cohen P, Finckh A, Allaz AF, Vischer TL.

Ann Rheum Dis. 2004 Mar;63(3):290-6.

3.

Neurophysiologic evidence for a central sensitization in patients with fibromyalgia.

Desmeules JA, Cedraschi C, Rapiti E, Baumgartner E, Finckh A, Cohen P, Dayer P, Vischer TL.

Arthritis Rheum. 2003 May;48(5):1420-9.

4.

Importance of species-specific antigens in the serodiagnosis of Chlamydia trachomatis reactive arthritis.

Bas S, Genevay S, Schenkel MC, Vischer TL.

Rheumatology (Oxford). 2002 Sep;41(9):1017-20.

PMID:
12209035
5.

A six year prospective study of a cohort of patients with fibromyalgia.

Baumgartner E, Finckh A, Cedraschi C, Vischer TL.

Ann Rheum Dis. 2002 Jul;61(7):644-5.

6.

Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors.

Bas S, Perneger TV, Kunzle E, Vischer TL.

Ann Rheum Dis. 2002 Jun;61(6):505-10.

7.
8.

Indirect evidence of intra-articular immunoglobulin G synthesis in patients with Chlamydia trachomatis reactive arthritis.

Bas S, Muzzin P, Fulpius T, Buchs N, Vischer TL.

Rheumatology (Oxford). 2001 Jul;40(7):801-5.

PMID:
11477285
10.
11.

Standing committee on epidemiology and health services research: past, present, and future

Vischer TL, Van Der Linden SJ.

Ann Rheum Dis. 2000 Oct;59(10):773-4. No abstract available.

12.

The representation of the back in idiomatic expressions--do idioms value the body?

Cedraschi C, Bove D, Perrin E, Vischer TL.

Joint Bone Spine. 2000;67(4):319-25.

PMID:
10963081
13.

The first annual EULAR congress

Van De Putte LB, Vischer TL.

Ann Rheum Dis. 2000 Jun;59(6):401. No abstract available.

14.

Is chronic non-specific low back pain chronic? Definitions of a problem and problems of a definition.

Cedraschi C, Robert J, Goerg D, Perrin E, Fischer W, Vischer TL.

Br J Gen Pract. 1999 May;49(442):358-62.

16.

Humoral immunity in Chlamydia trachomatis arthritis.

Bas S, Vischer TL.

Rev Rhum Engl Ed. 1999 Jan 30;66(1 Suppl):34S-35S; discussion 36S. Review. No abstract available.

PMID:
10063522
17.

Chlamydia trachomatis antibody detection and diagnosis of reactive arthritis.

Bas S, Vischer TL.

Br J Rheumatol. 1998 Oct;37(10):1054-9.

PMID:
9825743
18.

An extended HLA-DQ-DR haplotype rather than DRB1 alone contributes to RA predisposition.

Zanelli E, Huizinga TW, Guerne PA, Vischer TL, Tiercy JM, Verduyn W, Schreuder GM, Breedveld FC, de Vries RR.

Immunogenetics. 1998 Nov-Dec;48(6):394-401.

PMID:
9799335
19.

Health care providers should use a common language in relation to low back pain patients.

Cedraschi C, Nordin M, Nachemson AL, Vischer TL.

Baillieres Clin Rheumatol. 1998 Feb;12(1):1-15. Review.

PMID:
9668954
20.

Conservative inhospital management of low back pain patients. Factors predicting two-year outcomes.

Zufferey P, Cedraschi C, Vischer TL.

Rev Rhum Engl Ed. 1998 May;65(5):320-7.

PMID:
9636951
21.

[Current approach to low back pain].

Baumgartner E, Vischer TL.

Schweiz Med Wochenschr. 1997 Nov 15;127(46):1901-10. Review. German.

PMID:
9454313
22.

Rheumatology in Switzerland.

Vischer TL.

Br J Rheumatol. 1997 Nov;36(11):1205-6. No abstract available.

PMID:
9402865
23.

Molecular analysis of HLA-DR polymorphism in polymyalgia rheumatica. Swiss Group for Research on HLA in Polymyalgia Rheumatica.

Guerne PA, Salvi M, Seitz M, Bruhlmann P, Rivier G, Frey D, Mermillod B, Vischer TL, Tiercy JM.

J Rheumatol. 1997 Apr;24(4):671-6.

PMID:
9101500
24.

Evaluation of commercially available tests for Chlamydia nucleic acid detection in synovial fluid of patients.

Bas S, Ninet B, Delaspre O, Vischer TL.

Br J Rheumatol. 1997 Feb;36(2):198-202.

PMID:
9133929
25.
26.

The value of isotype determination of serum antibodies against Chlamydia for the diagnosis of Chlamydia reactive arthritis.

Bas S, Cunningham T, Kvien TK, Glennås A, Melby K, Vischer TL.

Br J Rheumatol. 1996 Jun;35(6):542-7.

PMID:
8670574
27.
28.

The role of congruence between patient and therapist in chronic low back pain patients.

Cedraschi C, Robert J, Perrin E, Fischer W, Goerg D, Vischer TL.

J Manipulative Physiol Ther. 1996 May;19(4):244-9.

PMID:
8734399
29.
31.
32.

Association between human parvovirus B19 infection and arthritis.

Cassinotti P, Bas S, Siegl G, Vischer TL.

Ann Rheum Dis. 1995 Jun;54(6):498-500.

33.

Oral desensitization in the treatment of human immune diseases.

Vischer TL.

Z Rheumatol. 1995 May-Jun;54(3):155-7. Review.

PMID:
7544938
34.

Oral desensitisation in rheumatoid arthritis.

Vischer TL, Van Eden W.

Ann Rheum Dis. 1994 Nov;53(11):708-10. Review. No abstract available.

35.

[Chlamydia infections in rheumatology].

Bas S, Vischer TL.

Rev Rhum Ed Fr. 1994 Oct;61(9):569-73. Review. French. No abstract available.

PMID:
7858589
36.

Palindromic syndrome: appearance of chondrocalcinosis after 47 years of evolution.

Gabay C, Vischer TL, Guerne PA.

J Rheumatol. 1993 Sep;20(9):1610-2.

PMID:
8164227
37.

Subreum (OM-8980): an anti-arthritic E. coli extract.

Vischer TL.

Clin Exp Rheumatol. 1993 Mar-Apr;11 Suppl 8:S121-3. Review. No abstract available.

PMID:
8324936
38.

Electroacupuncture in fibromyalgia: results of a controlled trial.

Deluze C, Bosia L, Zirbs A, Chantraine A, Vischer TL.

BMJ. 1992 Nov 21;305(6864):1249-52.

39.

Role of physical therapy in the management of common low back pain.

Tan JC, Roux EB, Dunand J, Vischer TL.

Baillieres Clin Rheumatol. 1992 Oct;6(3):629-55. Review. No abstract available.

PMID:
1477895
40.

Medical approach to low back pain.

Roux EB, Vischer TL, Brisson PM.

Baillieres Clin Rheumatol. 1992 Oct;6(3):607-27. Review. No abstract available.

PMID:
1477894
41.

The role of prior knowledge on back-pain education.

Cedraschi C, Reust P, Roux E, Vischer TL.

J Spinal Disord. 1992 Sep;5(3):267-76.

PMID:
1387823
42.

[Arthropathy due to hemochromatosis: often inaugural manifestation of the disease].

Aellen P, Guerne PA, Zenagui D, Vischer TL.

Schweiz Med Wochenschr. 1992 May 30;122(22):842-9. Review. French.

PMID:
1604289
43.

Production of neutrophil activating peptide-1 (NAP-1/IL-8) by blood and synovial fluid mononuclear cells from patients with arthritis.

Bas S, Vischer TL, Ceska M, Zsak M, Lindley I, Dewald B, Baggiolini M.

Clin Exp Rheumatol. 1992 Mar-Apr;10(2):137-41. Erratum in: Clin Exp Rheumatol 1992 Jul-Aug;10(4):ii. Isak M [corrected to Zsak M].

PMID:
1505106
44.

Diet and fatty acids: can fish substitute for fish oil?

Fahrer H, Hoeflin F, Lauterburg BH, Peheim E, Levy A, Vischer TL.

Clin Exp Rheumatol. 1991 Jul-Aug;9(4):403-6.

PMID:
1934691
45.
46.

Human alpha 2-macroglobulin as an inhibitor of insoluble trypsin.

Heumann D, Burger D, Vischer TL.

Biochem Biophys Res Commun. 1989 Nov 30;165(1):14-9.

PMID:
2480121
47.

Synovial fluid hydroxyapatite crystals: detection thresholds of two methods.

Cunningham T, Uebelhart D, Very JM, Fallet GH, Vischer TL.

Ann Rheum Dis. 1989 Oct;48(10):829-31.

48.

Detection of parvovirus in a patient with "reactive arthritis" by in situ hybridization.

Kandolf R, Kirschner P, Hofschneider PH, Vischer TL.

Clin Rheumatol. 1989 Sep;8(3):398-401.

PMID:
2805616
49.

Cell surface antigen CD5 is a marker for activated human B cells.

Werner-Favre C, Vischer TL, Wohlwend D, Zubler RH.

Eur J Immunol. 1989 Jul;19(7):1209-13.

PMID:
2474446
50.

[Rheumatologic complications in patients treated with intermittent hemodialysis].

Roux E, Leski M, Vischer TL.

Schweiz Rundsch Med Prax. 1989 May 23;78(21):609-13. Review. French.

PMID:
2662329

Supplemental Content

Loading ...
Support Center